It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
The best way to shortlist great mutual funds is to ensure solid performance, diversification, and low fees. Some are better than others, but utilizing the Zacks Mutual Fund Rank, we have identified three mutual funds that could be solid additions to one's retirement portfolio.
Here are the funds that have achieved the Zacks Mutual Fund Rank #1 (Strong Buy) and have low fees.
Columbia Small Cap Value I Class R4 (CVVRX): 1.01% expense ratio and 0.81% management fee. CVVRX is a Small Cap Value fund, and these funds are known for investing in companies with market caps under $2 billion. With annual returns of 13% over the last five years, this fund is a winner.
QS Global Equity 1 (LMPEX): 1.1% expense ratio and 0.75% management fee. LMPEX is a Non US - Equity option, focusing their investments acoss emerging and developed markets, and can often extend across cap levels too. LMPEX, with annual returns of 14.55% over the last five years, is a well-diversified fund with a long track record of success.
PGIM QMA Large Cap Core Equity A (PTMAX) is an attractive large-cap allocation. PTMAX is part of the Large Cap Blend section, and these mutual funds most often invest in firms with a market capitalization of $10 billion or more. By investing in bigger companies, these funds offer more stability, and are often well-suited for investors with a "buy and hold" mindset. PTMAX has an expense ratio of 0.72%, management fee of 0.35%, and annual returns of 15.05% over the past five years.
These examples highlight the fact that there are some astonishingly good mutual funds out there. If your advisor has you in the good ones, bravo! If not, you may need to have a talk.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>Get Your Free (CVVRX): Fund Analysis Report
Get Your Free (PTMAX): Fund Analysis Report
Get Your Free (LMPEX): Fund Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
